Get 20% Free Customization In This Report

Buy this report from - $3690

Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms and Services), By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Other Technologies) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Medical Devices & Supplies	LI_172048	Pages: 162	Apr 2017 \| 3906 Views
Author's : Onkar Sumant, Sohail Shaikh	Tables: 75	Charts: 31	Formats*:

Next Generation Sequencing (NGS) Market Overview:

Global Next Generation Sequencing (NGS) Market was valued at $3,567 million in 2015, and is expected to reach $12,801 million in 2022, supported by a CAGR of 19.9% during the forecast period 2014 to 2022. NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing. NGS minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method.

NGS is used to execute various applications such as biomarker discovery, oncology studies, personalized medicine, agricultural & animal research, and others. NGS has streamlined nucleotide analysis and has widely replaced conventional tools of genomics, especially microarray efficiently. The demand for NGS has increased significantly owing to surge in NGS applications and rise in technological advancements in NGS. In addition, the growth in number of genome mapping programs throughout the world and increase in R&D investment drives the market growth.

Global Next Generation Sequencing Market Segmentation

The next generation sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, the market is segmented into consumables, platforms, and services. The consumables product segment is further bifurcated as sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. In the NGS product segment, consumables occupied dominant share in 2015, and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and are needed to perform other pre-requisite steps of NGS.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.

Drivers and Restraints

Global Next Generation Sequencing Market: Key product segment

The consumables product segment holds a significant share in the global next generation sequencing market. This trend is expected to continue during the forecast period.

Global Next Generation Sequencing, by Product, 2015 (%)

The key players operating in the global NGS market include Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Perkinelmer, Inc., Genomatix GmbH, and PierianDx.

Other prominent players in the value chain include Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., Partek Inc., New England Biolabs, Inc. and Myriad Genetics, Inc.

Key Benefits of Next Generation Sequencing (Ngs) Market:

The study provides an in-depth analysis of the global next generation sequencing market, with current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities is discussed.
Key market players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the market.
Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Next Generation Sequencing (Ngs) Market Key Segments

By Product

Consumables
- Sample Preparation Consumables
  - DNA Fragmentation, End Repair, A-Tailing and Size Selection
  - Library Preparation & Target Enrichment
  - Quality Control
- Other Consumables
Platforms
- HiSeq
- MiSeq
- Ion Torrent
- SOLiD
- Pacbio Rs II and Sequel System
- Other Sequencing Platforms
Services
- Sequencing Services
  - RNA Sequencing
  - Whole Exome Sequencing
  - Whole Genome Sequencing
  - Targeted Sequencing
  - Chip Sequencing
  - De Novo Sequencing
  - Methyl Sequencing
- Data Management Services
  - NGS Data Analysis Services
  - NGS Data Analysis Software & Workbenches
  - NGS Storage, Management and Cloud Computing Solutions

By Application

Diagnostics
Biomarkers and Cancer
Reproductive Health
Personalized Medicine
Agriculture and Animal Research
Other Applications

By Technology

Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Other Technologies

By End User

Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Technological advancements in NGS
3.5.1.2. Surge in applications of NGS
3.5.1.3. Increase in partnerships and collaborations
3.5.1.4. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Standardization concerns over NGS based diagnostics
3.5.2.2. Lack of skilled professionals
3.5.2.3. Ethical and legal limitations

3.5.3. Opportunities

3.5.3.1. Lucrative opportunities in emerging markets
3.5.3.2. Cloud computing: potential data management service

Chapter: 4 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. CONSUMABLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Sample preparation consumables

4.2.4.1. DNA fragmentation, end repair, A-tailing, and size selection
4.2.4.2. Library preparation & target enrichment
4.2.4.3. Quality Control

4.2.1. Other consumables

4.3. PLATFORMS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Hiseq series
4.3.5. Miseq series
4.3.6. ION Torrent
4.3.7. SOLiD
4.3.8. Pacbio Rs II and Sequel system
4.3.9. Other Sequencing Platforms

4.4. SERVICES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
4.4.4. Sequencing services

4.4.4.1. Market size & forecast
4.4.4.2. RNA sequencing
4.4.4.3. Whole exome sequencing
4.4.4.4. Whole genome sequencing
4.4.4.5. Targeted sequencing
4.4.4.6. Chip sequencing
4.4.4.7. De Novo sequencing
4.4.4.8. Methyl sequencing

4.4.1. Data management services

4.4.1.1. NGS data analysis services
4.4.1.2. NGS data analysis software & workbenches
4.4.1.3. NGS storage, management, and cloud computing solutions

Chapter: 5 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. BIOMARKERS AND CANCER

5.2.1. Market size & forecast

5.3. DIAGNOSTICS

5.3.1. Market size & forecast

5.4. REPRODUCTIVE HEALTH

5.4.1. Market size & forecast

5.5. PERSONALIZED MEDICINE

5.5.1. Market size & forecast

5.6. AGRICULTURE AND ANIMAL RESEARCH

5.6.1. Market size & forecast

5.7. OTHER APPLICATIONS

5.7.1. Market size & forecast

Chapter: 6 GLOBAL NEXT GENERATION SEIQNCING MARKET, BY TECHNOLOGY

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. SEQUENCING BY SYNTHESIS (SBS)

6.2.1.1. Market size & forecast

6.3. ION SEMICONDUCTOR SEQUENCING (IOS)
6.4. SEQUENCING BY LIGATION (SBL)

6.4.1. Market size & forecast

6.5. PYROSEQUENCING

6.5.1. Market size & forecast

6.6. SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)

6.6.1. Market size & forecast

6.7. OTHER TECHNOLOGIES

6.7.1. Market size & forecast

Chapter: 7 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USERS

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

7.2.1. Market size & forecast

7.3. PHARMACEUTICAL COMPANIES

7.3.1. Market size & forecast

7.4. BIOTECHNOLOGY COMPANIES

7.4.1. Market size & forecast

7.5. HOSPITALS & CLINICS

7.5.1. Market size & forecast

Chapter: 8 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size & forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. Mexico

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. AGILENT TECHNOLOGIES, INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments

9.2. BEIJING GENOMICS INSTITUTE

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments

9.3. GENOMATIX GMBH

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio

9.4. ILLUMINA, INC.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments

9.6. PERKINELMER, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments

9.7. PIERIANDX

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments

9.8. QIAGEN N.V.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. ROCHE HOLDING AG

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. THERMO FISHER SCIENTIFIC, INC.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2. GLOBAL NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. DNA FRAGMENTATION, END REPAIR, A-TAILING & SIZE SELECTION: KEY PRODUCTS
TABLE 4. LIBRARY PREPARATION & TARGET ENRICHMENT: KEY PRODUCTS
TABLE 5. GLOBAL NEXT GENERATION SEQUENCING PLATFORM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6. GLOBAL NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 7. SEQUENCING SERVICES GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8. NGS DATA ANALYSIS SOFTWARE & WORKBENCHES: KEY PRODUCTS
TABLE 9. NGS STORAGE MANAGEMENT AND CLOUD COMPUTING: KEY PRODUCTS
TABLE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 11. BIOMARKERS AND CANCER NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 12. DIAGNOSTICS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 13. REPRODUCTIVE HEALTH NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 14. PERSONALISED MEDICINE NEXT GENERATION SEQUENCING, BY REGION, 2014-2022 ($MILLION)
TABLE 15. AGRICULTURE AND ANIMAL RESEARCH NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 16. OTHER APPLICATIONS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 18. SEQUENCING BY SYNTHESIS TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 19. ION SEMICONDUCTOR SEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 20. SEQUENCING BY LIGATION TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 21. PYROSEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET TECHNOLOGY, BY REGION, 2014-2022 ($MILLION)
TABLE 22. SINGLE-MOLECULE-REAL-TIME-SEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 23. OTHER TECHNOLOGIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 24. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 25. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 26. PHARMACEUTICAL COMPANIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 27. BIOTECHNOLOGY COMPANIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 28. HOSPITALS & CLINICS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 29. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 30. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 31. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 32. NORTH AMERICA CONSUMABLES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 33. NORTH AMERICA PLATFORMS NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 34. NORTH AMERICA SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35. NORTH AMERICA SEQUENCING SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 36. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION , 2014-2022 ($MILLION)
TABLE 37. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY , 2014-2022 ($MILLION)
TABLE 38. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY END USER , 2014-2022 ($MILLION)
TABLE 39. EUROPE NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40. EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 41. EUROPE NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 42. EUROPE NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 43. EUROPE NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 44. EUROPE NEXT GENERATION SEQUENCING SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 45. EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 46. EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 47. EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 48. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 49. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 50. ASIA-PACIFIC NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 51. ASIA-PACIFIC NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 52. ASIA-PACIFIC NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 53. ASIA-PACIFIC NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 57. LAMEA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 58. LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 59. LAMEA NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 60. LAMEA NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 61. LAMEA NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 62. LAMEA NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 63. LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 64. LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 65. LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 66. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 67. THERMO FISHER SCIENTIFIC, INC.,: COMPANY SNAPSHOT
TABLE 68. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,: COMPANY SNAPSHOT
TABLE 69. BEIJING GENOMICS INSTITUTE: COMPANY SNAPSHOT
TABLE 70. QIAGEN N.V.,: COMPANY SNAPSHOT
TABLE 71. LIFE SCIENCES CORPORATION (ROCHE HOLDING AG) : COMPANY SNAPSHOT
TABLE 72. AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT
TABLE 73. PERKINELMER, INC. : COMPANY SNAPSHOT
TABLE 74. GENOMATIX GMBH: COMPANY SNAPSHOT
TABLE 75. PIERIANDX: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
FIGURE 2. PATENT ANALYSIS BY YEAR
FIGURE 3. PATENT ANALYSIS BY REGION
FIGURE 4. BARGAINING POWER OF BUYERS
FIGURE 5. BARGAINING POWER OF SUPPLIERS
FIGURE 6. THREAT OF NEW ENTRANTS
FIGURE 7. THREAT OF SUBSTITUTION
FIGURE 8. COMPETITIVE RIVALRY
FIGURE 9. DRIVERS AND RESTRAINTS: GLOBAL NEXT GENERATION SEQUENCING MARKET
FIGURE 10. NGS MARKET: PRODUCT & SERVICES SEGMENATION
FIGURE 11. U.S. NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 12. CANADA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 13. MEXICO NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 14. MEXICO NEXT GENERATION SEQUENCING MARKET, 2014-2022
FIGURE 15. GERMANY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 16. FRANCE NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 17. UK NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 18. ITALY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 19. SPAIN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 20. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 21. JAPAN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 22. CHINA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 23. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 24. INDIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 25. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 26. TAIWAN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 28. BRAZIL NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 29. TURKEY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 30. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 31. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)

Next generation sequencing has positively impacted diverse fields of research innovation and development. Biomarker discovery, oncology studies, drug development, personalized genomics, and reproductive health are some of the widely-known applications of this technique. Similarly, NGS has also contributed significantly in agricultural & animal and forensic research. Next generation sequencing is expected to witness high adoption rate with increase in distinct applications and interventions such as diagnostics, biomarker discovery, personalized medicine, and others. The NGS market has gained momentum in the research, innovation, and development sector owing to the increase in genome mapping projects throughout the world, significant technological advancements in NGS and surge in collaborations and partnerships among NGS product manufacturing companies. In addition, rise in awareness about NGS and its advantages also drives the market growth.

The demand of NGS has soared greatly due to the reduced cost of sequencing and increase in the total number of produced sequence reads per run. However, standardization concerns in NGS diagnostics and ethical & legal limitations restrict market growth. At present academic & government research institutes are the largest end users of NGS, followed by pharmaceutical companies, biotechnology companies, and hospitals & clinics. The biotechnology end-user segment is expected to exhibit the highest growth rate throughout the forecast period. However, the utilization of NGS is higher in academic & government research institutes compared to other end users as NGS is routinely employed in hospitals for genomics research, biomarkers detection, transcriptomics research, and other purposes.

Increase in awareness regarding NGS and investment in research, innovation, and development greatly fuel the demand for novel NGS technologies, especially nanopore sequencing. The employment of technologically advanced NGS products is highest in North America, owing to the increase in adoption of NGS products and technologies, followed by Europe and Asia-Pacific.

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Next Generation Sequencing (NGS) Market Overview: